Examination of data from our regional registry of congenital anomalies
indicated that 217 children with Down syndrome (DS) were registered (
liveborn, stillborn or termination of pregnancy) to mothers living in
the Strasbourg area from 1980 to 1992 inclusive. This represents a per
iod prevalence of 1.25 per 1000 total births. From 1980 to 1987, 93 ch
ildren with DS were registered (prevalence of 0.79 per 1000) whereas f
rom 1988 to 1992, 124 trisomic 21 were identified (prevalence of 1.81
per 1000). In our country since 1980, prenatal diagnosis is offered, f
ree of charge, to all women being 38 years old or more. The percentage
of women in whom prenatal diagnosis was performed was ''en plateau ''
since 1986, around 60 per cent. No screening program based on detecti
on of markers in maternal serum (AFP, hCG, U3) is available in our reg
ion. A changing pattern of risk in relation to maternal age was identi
fied. In the general population, women under 35 years gave births to 9
1.7 per cent of all children in 1986 and to 81.1 per cent of all child
ren in 1990. From 1980 to 1987 34.7 per cent of the children with DS w
ere registered in mothers older than 35 years of age, from 1988 to 199
2 this percentage was 46.3. From 1982 to 1987, 33 DS were born alive f
rom mothers over 35 years whereas from 1988 to 1992, 25 livebirths DS
were born from mothers over 35 years although interruption of DS pregn
ancies was more frequent in women older than 35 years of age. The tota
l number of liveborn DS born during these two periods of time was 74 a
nd 84, respectively. This study demonstrated that a screening programm
e by maternal serum markers is needed in our region.